Detalhe da pesquisa
1.
Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy.
Nat Immunol;
23(8): 1273-1283, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35835962
2.
The transcription factor IRF2 drives interferon-mediated CD8+ T cell exhaustion to restrict anti-tumor immunity.
Immunity;
55(12): 2369-2385.e10, 2022 12 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36370712
3.
Tumor microenvironmental plasmacytoid dendritic cells contribute to breast cancer lymph node metastasis via CXCR4/SDF-1 axis.
Breast Cancer Res Treat;
174(3): 679-691, 2019 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30632021
4.
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Mol Cancer;
16(1): 57, 2017 03 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28270211
5.
Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient.
Nat Commun;
15(1): 1094, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38321065
6.
Mass cytometry immunostaining protocol for multiplexing clinical samples.
STAR Protoc;
3(3): 101643, 2022 09 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36052346
7.
Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer.
J Immunother Cancer;
10(3)2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35288469
8.
The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4+ T cell polarization in inflammatory and non-inflammatory breast cancer patients.
PLoS One;
14(5): e0217550, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31145753
9.
Inflammatory breast cancer: Activation of the aryl hydrocarbon receptor and its target CYP1B1 correlates closely with Wnt5a/b-ß-catenin signalling, the stem cell phenotype and disease progression.
J Adv Res;
16: 75-86, 2019 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30899591
10.
Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials.
Front Oncol;
9: 415, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31165047
11.
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE).
J Immunother Cancer;
7(1): 72, 2019 03 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30867072